Therapeutic potential of tyrosine kinase 2 in autoimmunity

Author： Liang Yan   Zhu Yan   Xia Yi   Peng Hui   Yang Xiao-Ke   Liu Yan-Yan   Xu Wang-Dong   Pan Hai-Feng   Ye Dong-Qing  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.18, Iss.5, 2014-05, pp. : 571-580

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Therapeutic Potential of Inhibiting Bruton's Tyrosine Kinase, (BTK)

By  

Current Pharmaceutical Design, Vol. 10, Iss. 15, 2004-06 ,pp. : 1757-1766

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Updates on the Therapeutic Potential of HER2 Tyrosine Kinase Inhibitors for the Treatment of Breast Cancer

By  

Current Cancer Drug Targets, Vol. 18, Iss. 4, 2018-04 ,pp. : 306-327

Bentham Science Publishers

Access to resources Recommend Favorite

Oncogenic Variant RON160 Expression in Breast Cancer and its Potential as a Therapeutic Target by Small Molecule Tyrosine Kinase Inhibitor

By  

Current Cancer Drug Targets, Vol. 13, Iss. 6, 2013-07 ,pp. : 686-697

Bentham Science Publishers

Access to resources Recommend Favorite

Pyruvate Kinase M2: Regulatory Circuits and Potential for Therapeutic Intervention

By  

Current Pharmaceutical Design, Vol. 20, Iss. 15, 2014-05 ,pp. : 2595-2606

Bentham Science Publishers

Access to resources Recommend Favorite

Tyrosine phosphatases: cellular functions and therapeutic potential

By Klann A.G.   Miller R.A.   Norman E.D.   Klann E.  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 5, 2000-05 ,pp. : 675-683

Informa Healthcare

Access to resources Recommend Favorite